Levothyroxine EP Impurity D is a structurally related degradation byproduct of levothyroxine, characterized by the loss of a methylamino group and retention of four iodine atoms on a substituted tetrahydrobenzofuran ring system. Its core scaffold retains conjugated aromaticity with hydroxyl and ketone functionalities at positions 3 and 5 of the phenolic moiety, while the side chain lacks the N-methyl substitution present in the parent drug. This impurity arises via oxidative deamination during synthesis or storage, forming a stable, fully iodinated cyclic ether derivative. It serves as a critical HPLC reference standard for quantitative impurity profiling in levothyroxine bulk drug substance analysis.
On Request| Std | Catalog # | Quantity | Price |
|---|---|---|---|
| USP | 1A11700 โ | 25 mg | USD 850.00 |
C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(=O)O
InChI=1S/C14H8I4O4/c15-8-4-7(5-9(16)13(8)21)22-14-10(17)1-6(2-11(14)18)3-12(19)20/h1-2,4-5,21H,3H2,(H,19,20)
PPJYSSNKSXAVDB-UHFFFAOYSA-N